Lee, C.G. Lee, E.H. Pan, C.-H. Kang, K. Rhee, K.-J. 2024-01-20T01:02:10Z 2024-01-20T01:02:10Z 2021-08-31 2017-08 2352-3409 https://pubs.kist.re.kr/handle/201004/122501 Here, we report animal experimental data associated with the article entitled “AKR1B10-inhibitory Selaginella tamariscina extract and amentoflavone decrease the growth of A549 human lung cancer cells in vitro and in vivo“ (Jung et al., 2017) [1]. We tested the synergistic anti-tumor effects of Selaginella tamariscina extract and amentoflavone combined with doxorubicin hydrochloride in a nude mouse xenograft model of A549 human lung cancer cells. In our experiment, Selaginella tamariscina extract and amentoflavone were administered orally; and doxorubicin hydrochloride was injected intraperitoneally. We expect our preliminary data will be helpful to the development of the anticancer agent using Selaginella tamariscina extract or amentoflavone. ？ 2017 The Authors English Elsevier Inc. Data on the anti-tumor effects of Selaginella tamariscina extract and amentoflavone combined with doxorubicin in mice Article 10.1016/j.dib.2017.05.023 1 Data in Brief, v.13, pp.162 - 165 Data in Brief 13 162 165 N scopus 2-s2.0-85019739140 Data Paper Amentoflavone Anti-tumor Doxorubicin Selaginella tamariscina